Sigma-Tau公司宣布儿童VSL#3益生菌登陆美国

    October 16, 2012 —Sigma-Tau Pharmaceuticals, Inc., announced today the U.S. launch of VSL#3® JUNIOR, a once-a-day, high-potency probiotic medical food for the dietary management of children who suffer from irritable bowel syndrome (IBS) and ulcerative colitis (UC). Unlike other marketed probiotics, VSL#3® JUNIOR is presently the only probiotic sold as a medical food for IBS and UC. Refrigerated VSL#3® JUNIOR contains 8 proprietary strains of 225 billion live bacteria, making it approximately 50 times more potent than the average probiotic.
    2012年10月16日，Sigma-Tau公司宣布儿童VSL#3益生菌登陆美国。该产品是用于患有肠易激综合征、溃疡性结肠炎儿童的膳食管理的保健食品。与其他益生菌不同，VSL#3益生菌是目前唯一一个作为治疗肠易激综合征和溃疡性结肠炎的保健食品。冻干的VSL#3益生菌含有8大类2250亿株活菌，效果是普通益生菌的50倍。（信息来源：Sigma-Tau公司官网）